GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Total Equity

GeneOne Life Science (XKRX:011000) Total Equity : ₩111,489 Mil (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Total Equity?

GeneOne Life Science's total equity for the quarter that ended in Dec. 2023 was ₩111,489 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


GeneOne Life Science Total Equity Historical Data

The historical data trend for GeneOne Life Science's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Total Equity Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24,060.17 98,508.79 206,506.77 181,471.29 111,489.21

GeneOne Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181,471.29 176,787.39 164,130.59 158,346.61 111,489.21

GeneOne Life Science Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

GeneOne Life Science's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=151007.705-39518.498
=111,489

GeneOne Life Science's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=151007.705-39518.498
=111,489

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GeneOne Life Science Total Equity Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneOne Life Science (XKRX:011000) Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science (XKRX:011000) Headlines

No Headlines